CYTORI THERAPEUTICS INC - COM (CYTX)

CUSIP: 23283K105

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
17,348,696
Share change
+2,330,842
Total reported value
$41,411,644
Put/Call ratio
422%
Price per share
$2.39
Number of holders
72
Value change
+$5,445,119
Number of buys
38
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 23283K105?
CUSIP 23283K105 identifies CYTX - CYTORI THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM (CYTX) as of Q2 2014

As of 30 Jun 2014, CYTORI THERAPEUTICS INC - COM (CYTX) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,348,696 shares. The largest 10 holders included BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, BlackRock Fund Advisors, GOLDMAN CAPITAL MANAGEMENT INC, State Street Corp, MARATHON CAPITAL MANAGEMENT, PERKINS CAPITAL MANAGEMENT INC, NORTHERN TRUST CORP, and PRINCETON CAPITAL MANAGEMENT INC. This page lists 72 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.